可持续的抗凝固药物用于气候适应性护理
Bingwen Eugene Fan1, Kevin Milla2, Scott McAlister3
1Department of Haematology, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore; Department of Haematology, Northern Hospital, Epping, VIC, Australia; Northern Clinical Diagnostics and Thrombovascular Research Centre, Northern Health, Epping, VIC, Australia; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
将可持续性纳入抗凝固护理是减少医疗保健减少的关键.
科学领域:
- 环境科学与公共卫生 环境科学与公共卫生
- 临床药学和血栓瘤管理
背景情况:
- 包括药物生产,诊断和监测在内的抗凝护理对医疗保健的碳足迹作出了重大贡献.
- 越来越需要将临床实践与环境责任相协调.
研究的目的:
- 提出一个多学科的战略,将可持续性纳入抗凝固护理.
- 确定用于脱碳抗凝固管理的高影响干预点.
- 全球推广气候适应性血栓瘤护理.
主要方法:
- 使用生命周期评估方法量化整个抗凝路途径的排放量.
- 实施策略,如减少实验室检测,优化实验室操作,过渡到低碳抗凝剂,并促进抗血栓管理.
- 利用数字健康技术,循环经济原则和碳知情采购.
主要成果:
- 在抗凝固护理中确定了导致碳排放的关键领域.
- 提出可行的减少环境影响的战略,包括减少废物和可持续采购.
- 强调数字健康在实现低排放,以患者为中心的护理方面的作用.
结论:
- 系统层面的脱碳化战略对于可持续的抗凝固护理至关重要.
- 政策激励和全球参与对于公平实施至关重要.
- 整合可持续性使临床卓越与未来血栓瘤护理的气候责任保持一致.
相关概念视频
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care


